Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial
- PMID: 16246661
- DOI: 10.1016/j.contraception.2005.05.004
Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial
Abstract
Aim: This study evaluates the performance of extended use of a progesterone (P)-releasing vaginal ring (PVR) in nursing women.
Method: An open-label, noncomparative study on the safety and contraceptive efficacy of PVR replaced every 4 months of use (instead of 3 months) in 192 PVR acceptors. PVR use was initiated at day 59+/-2 (mean+/-SD) postpartum and continued until weaning or completing the use of three PVRs.
Results: Plasma P levels attained with the ring decreased from 17+/-1 to 14+/-1 nmol/L (mean+/-SE) from the third to the fourth month of use. These levels are still over the critical level of 10 nmol/L required for contraceptive protection. One pregnancy occurred in the third month of use of the second ring in 1998 woman-months of exposure. Extended use of the ring did not appear to affect breast-feeding performance or the rate of infant growth, and lactational amenorrhea was prolonged. No differences in the characteristics of bleeding between the third and fourth month of ring use were observed.
Conclusion: The results indicate that use of the PVR for 4 months represents a safe and effective contraceptive for nursing women.
Similar articles
-
Safety of the progesterone-releasing vaginal ring (PVR) among lactating women: A systematic review.Contraception. 2016 Sep;94(3):253-61. doi: 10.1016/j.contraception.2015.04.001. Epub 2015 Apr 11. Contraception. 2016. PMID: 25869631 Review.
-
Progesterone vaginal ring for contraceptive use during lactation.Contraception. 2010 Nov;82(5):428-34. doi: 10.1016/j.contraception.2010.05.016. Contraception. 2010. PMID: 20933116 Review.
-
Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.Contraception. 1999 Jul;60(1):9-14. doi: 10.1016/s0010-7824(99)00057-8. Contraception. 1999. PMID: 10549447 Clinical Trial.
-
Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.Contraception. 1997 Apr;55(4):225-32. doi: 10.1016/s0010-7824(97)00008-5. Contraception. 1997. PMID: 9179454 Clinical Trial.
-
Fertility regulation in nursing women. II. Comparative performance of progesterone implants versus placebo and copper T.Am J Obstet Gynecol. 1982 Sep 15;144(2):201-8. Am J Obstet Gynecol. 1982. PMID: 7114130 Clinical Trial.
Cited by
-
Development of Hormonal Intravaginal Rings: Technology and Challenges.Geburtshilfe Frauenheilkd. 2021 Jul;81(7):789-806. doi: 10.1055/a-1369-9395. Epub 2021 Jul 13. Geburtshilfe Frauenheilkd. 2021. PMID: 34276064 Free PMC article.
-
Non-clinical studies of progesterone.Climacteric. 2018 Aug;21(4):315-320. doi: 10.1080/13697137.2018.1463982. Epub 2018 May 23. Climacteric. 2018. PMID: 29790373 Free PMC article. Review.
-
Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.Drug Deliv Transl Res. 2011 Jun;1(3):185-93. doi: 10.1007/s13346-011-0024-4. Drug Deliv Transl Res. 2011. PMID: 25788239
-
New and emerging contraceptives: a state-of-the-art review.Int J Womens Health. 2014 Feb 19;6:221-34. doi: 10.2147/IJWH.S46811. eCollection 2014. Int J Womens Health. 2014. PMID: 24570597 Free PMC article. Review.
-
Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.Int J Womens Health. 2013 Oct 21;5:695-708. doi: 10.2147/IJWH.S34030. Int J Womens Health. 2013. PMID: 24174884 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
